COVID-19.рф: ИНФОРМАЦИЯ ПРОТИВ ПАНДЕМИИ

Поиск по репозиторию

Статья

Emergence of a novel GII.17 norovirus – end of the GII.4 era?

G. De, B. Van, H. Vennema, A. Podkolzin, J. Hewitt, F. Bucardo, K. Templeton, J. Mans, J. Nordgren, G. Reuter, M. Lynch, L. Rasmussen, N. Iritani, M. Chan, V. Martella, K. Ambert-Balay, J. Vinjé, P. White, M. Koopmans,
2021
https://doi.org/10.2807/1560-7917.es2015.20.26.21178

In the winter of 2014/15 a novel GII.P17-GII.17 norovirus strain (GII.17 Kawasaki 2014) emerged, as a major cause of gastroenteritis outbreaks in China and Japan. Since their emergence these novel GII.P17-GII.17 viruses have replaced the previously dominant GII.4 genotype Sydney 2012 variant in some areas in Asia but were only detected in a limited number of cases on other continents. This perspective provides an overview of the available information on GII.17 viruses in order to gain insight in the viral and host characteristics of this norovirus genotype. We further discuss the emergence of this novel GII.P17-GII.17 norovirus in context of current knowledge on the epidemiology of noroviruses. It remains to be seen if the currently dominant norovirus strain GII.4 Sydney 2012 will be replaced in other parts of the world. Nevertheless, the public health community and surveillance systems need to be prepared in case of a potential increase of norovirus activity in the next seasons caused by this novel GII.P17-GII.17 norovirus. © 2015, European Centre for Disease Prevention and Control (ECDC). All Rights Reserved.

Цитирование

Похожие публикации

Where do urologists stand in the era of novel coronavirus-2019 disease
T. Hughes, H. Ho, S. Shariat,
A new threat from an old enemy: Re-emergence of coronavirus (Review)
A. Docea, A. Tsatsakis, D. Albulescu,
Концепция возникновения новой коронавирусной инфекции
Дорофейчук В. Г., Шер С. А.,

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • G. De
    Erasmus MC, Department of Viroscience, Rotterdam, Netherlands
  • B. Van
    Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Netherlands
  • H. Vennema
    Central Research Institute of Epidemiology, Moscow, Russian Federation
  • A. Podkolzin
    Institute of Environmental Science and Research, Porirua, New Zealand
  • J. Hewitt
    Department of Microbiology, University of Leon, Nicaragua
  • F. Bucardo
    Department of Medical Microbiology, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom
  • K. Templeton
    Department of Medical Virology, University of Pretoria, Pretoria, South Africa
  • J. Mans
    Division of Molecular Virology, Department of Clinical and Experimental Medicine, Linköping University, Sweden
  • J. Nordgren
    Regional Laboratory of Virology, National Reference Laboratory of Gastroenteric Viruses, ÁNTSZ Regional Institute of State Public Health Service, Pécs, Hungary
  • G. Reuter
    Department of Microbiology, Mater Misericordiae University Hospital, Dublin, Ireland
  • M. Lynch
    Virology Surveillance and Research Section, Microbiological Diagnostics and Virology, Statens Serum Institut, Denmark
  • L. Rasmussen
    Department of Microbiology, Osaka City Institute of Public Health and Environmental Sciences, Tennoji-ku, Osaka, Japan
  • N. Iritani
    Department of Microbiology, Chinese University of Hong Kong, Hong Kong
  • M. Chan
    Università Aldo Moro di Bari, Valenzano, Italy
  • V. Martella
    National Reference Center for Enteric Viruses, Laboratory of Virology, CHU of Dijon, Dijon, France
  • K. Ambert-Balay
    Division of Viral Diseases, National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States
  • J. Vinjé
    School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia
  • P. White
  • M. Koopmans
Название журнала
  • Eurosurveillance
Том
  • 20
Выпуск
  • 26
Страницы
  • 1-8
Ключевые слова
  • amino acid; blood group H antigen; fucosyltransferase; virus protein; acute gastroenteritis; Article; biological accident; gene sequence; genetic susceptibility; genotype; geographic distribution; immunity; immunoassay; nonhuman; Norovirus; open reading frame; phylogeny; prevalence; real time polymerase chain reaction; sequence analysis; virus capsid
Издатель
  • European Centre for Disease Prevention and Control (ECDC)
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus
COVID-19.рф: Информация против пандемии

Адрес: 115114, Москва, ул. Летниковская, д. 4, стр.5, офис 2.4
тел.\факс: +7(499)754-99-94, доб. 502
e-mail: covid19@neicon.ru

Проект реализуется с использованием гранта Президента Российской Федерации на развитие гражданского общества, предоставленного Фондом президентских грантов.

Содержимое сайта, если не указано иное, опубликовано в соответствии с лицензией Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная (CC BY 4.0). Права на материалы, переданные партнерами проекта, принадлежат их правообладателям.

© 2025 NEICON